AbbVie 2014 Annual Report Download - page 120
Download and view the complete annual report
Please find page 120 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110 -
111 -
112 -
113 -
114 -
115 -
116 -
117 -
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
 |
 |
13NOV201221352027
14FEB201503004427
PROXY STATEMENT
Table of Contents
Proxy Statement Summary ............................................................... 1
Information about the Annual Meeting ...................................................... 5
Who Can Vote ...................................................................... 5
Notice and Access ................................................................... 5
Voting by Proxy ..................................................................... 5
Revoking a Proxy .................................................................... 5
Discretionary Voting Authority ........................................................... 5
Quorum and Vote Required to Approve Each Item on the Proxy .................................... 6
Effect of Broker Non-Votes and Abstentions .................................................. 6
Inspectors of Election ................................................................. 6
Cost of Soliciting Proxies ............................................................... 6
AbbVie Savings Plan .................................................................. 6
Corporate Governance Materials .......................................................... 6
Information Concerning Director Nominees (Item 1) ............................................. 7
The Board of Directors and its Committees ................................................... 11
Communicating with the Board of Directors .................................................. 14
Director Compensation ................................................................. 15
Securities Ownership ................................................................... 17
Executive Compensation ................................................................ 19
Compensation Discussion and Analysis ..................................................... 19
Compensation Committee Report ......................................................... 32
Compensation Risk Assessment .......................................................... 32
Summary Compensation Table ........................................................... 33
2014 Grants of Plan-Based Awards ........................................................ 37
2014 Outstanding Equity Awards at Fiscal Year End ............................................ 38
2014 Option Exercises and Stock Vested .................................................... 40
Pension Benefits .................................................................... 40
Nonqualified Deferred Compensation ...................................................... 44
Potential Payments upon Termination or Change in Control ....................................... 44
Ratification of Ernst & Young LLP as AbbVie’s Independent Registered Public Accounting Firm (Item 2) ......... 48
Audit Information ..................................................................... 49
Audit Committee Report ................................................................ 50
Say on Pay—Advisory Vote on the Approval of Executive Compensation (Item 3) ........................ 51
Additional Information ................................................................. 52